Iron overload is a predictable and life-threatening complication in patients dependent on the regular transfusion of RBCs. The aims of this study were to investigate the efficacy and safety of deferiprone in a variety of pediatric hematologic and/or oncologic patients with a high iron overload.
CITATION STYLE
Won, S. C., Han, D. K., Seo, J. J., Chung, N. G., Park, S. K., Park, K. B., … Lyu, C. J. (2010). Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients. The Korean Journal of Hematology, 45(1), 58. https://doi.org/10.5045/kjh.2010.45.1.58
Mendeley helps you to discover research relevant for your work.